A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein

Genes Chromosomes and Cancer

Volumn 36, Issue 1, 2003, Pages 26-36

  Wechsler, Daniel S ^a   Engstrom, Lars D ^a   Alexander, Brian M ^a   Motto, David G ^a   Roulston, Diane ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; CLATHRIN ASSEMBLY LYMPHOID MYELOID LEUKEMIA PROTEIN; GENE PRODUCT; HYBRID PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AF10 GENE; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME BANDING PATTERN; CHROMOSOME INVERSION; CHROMOSOME REARRANGEMENT; ENDOCYTOSIS; FEMALE; GENE; GENE FUSION; GENE TRANSLOCATION; HUMAN; INFANT; INFANT DISEASE; INTRON; LEUKEMOGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

EID: 0037226808     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10136     Document Type: Article

References (53)

1. Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, Chen Z, Cimino G, Cordoba JC, Gu LJ, Hussein H, Ishii E, Kamel AM, Labra S, Magalhaes IQ, Mizutani S, Petridou E, de Oliveira MP, Yuen P, Wiemels JL, Greaves MF. 2001. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 61:2542-2546.
2. Ayton PM, Cleary ML. 2001a. MLL in normal and malignant hematopoiesis. In: Ravid K, Licht J, editors. Transcription factors: normal and malignant development of blood cells. New York: Wiley-Liss, p. 447-463.
3. Ayton PM, Cleary ML. 2001b. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20:5695-5707.
4. Bernard OA, Mauchauffe M, Mecucci C, Van den Berghe H, Berger R. 1994. A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL. Oncogene 9:1039-1045.
5. Beverloo HB, Le Coniat M, Wijsman J, Lillington DM, Bernard O, de Klein A, van Wering E, Welborn J, Young BD, Hagemeijer A. 1995. Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis. Cancer Res 55:4220-4224.
6. Bohlander SK, Bartels S. 1997. Identification and mapping of a transcriptional activation domain in CALM, the fusion partner of AF10 in the t(10;11)(p13;q14) found in the monocytic cell line U937. Med Genet 9:44.
7. Bohlander SK, Muschinsky V, Schrader K, Siebert R, Schlegelberger B, Harder L, Schemmel V, Fonatsch C, Ludwig WD, Hiddemann W, Dreyling MH. 2000. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia 14:93-99.
8. Borrow J, Stanton VP Jr, Andresen JM, Becher R, Behm FG, Chaganti RS, Civin CI, Disteche C, Dube I, Frischauf AM, Horsman D, Mitelman F, Volinia S, Watmore AE, Housman DE. 1996. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 14:33-41.
9. Carlson KM, Vignon C, Bohlander S, Martinez-Climent JA, Le Beau MM, Rowley JD. 2000. Identification and molecular characterization of CALM/AF10 fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia. Leukemia 14:100-104.
10. Caslini C, Shilatifard A, Yang L, Hess JL. 2000. The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation. Proc Natl Acad Sci USA 97:2797-2802.
11. Chaplin T, Bernard O, Beverloo HB, Saha V, Hagemeijer A, Berger R, Young BD. 1995. The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. Blood 86:2073-2076.
12. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie AN, King G, Rabbitts TH. 1996. An MLL-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 85:853-861.
13. Di Fiore PP, Gill GN. 1999. Endocytosis and mitogenic signaling. Curr Opin Cell Biol 11:483-488.
14. DiMartino JF, Cleary ML. 1999. MLL rearrangements in haematological malignancies: lessons from clinical and biological studies. Br J Haematol 106:614-626.
15. Dreyling MH, Martinez-Climent JA, Zheng M, Mao J, Rowley JD, Bohlander SK. 1996. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci USA 93:4804-4809.
16. Dreyling MH, Schrader K, Fonatsch C, Schlegelberger B, Haase D, Schoch C, Ludwig W, Loffler H, Buchner T, Wormann B, Hiddemann W, Bohlander SK. 1998. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis. Blood 91:4662-4667.
17. Felix CA, Lange BJ. 1999. Leukemia in infants. Oncologist 4:225-240.
18. Felix CA, Hosler MR, Slater DJ, Parker RI, Masterson M, Whitlock JA, Rebbeck TR, Nowell PC, Lange BJ. 1998. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children. J Pediatr Hematol Oncol 20:299-308.
19. Floyd S, De Camilli P. 1998. Endocyrosis proteins and cancer: a potential link? Trends Cell Biol 8:299-301.
20. Ford MG, Pearse BM, Higgins MK, Vallis Y, Owen DJ, Gibson A, Hopkins CR, Evans PR, McMahon HT. 2001. Simultaneous binding of PtdIns(4, 5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science 291:1051-1055.
21. Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, Greaves MF. 1997. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 94:13950-13954.
22. Golub TR, Weinstein HJ, Grier HE. 1997. Acute myelogenous leukemia. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, Third Ed. Philadelphia: Lippincott-Raven, p. 463-482.
23. Itoh T, Koshiba S, Kigawa T, Kikuchi A, Yokoyama S, Takenawa T. 2001. Role of the ENTH domain in phosphatidylinositol-4, 5-bisphosphate binding and endocytosis. Science 291:1047-1051.
24. Jones LK, Chaplin T, Shankar A, Neat M, Patel N, Samuel DP, Hill AS, Debernardi S, Bassini A, Young BD, Saha V. 2001. Identification and molecular characterisation of a CALM-AF10 fusion in acute megakaryoblastic leukaemia. Leukemia 15:910-914.
25. Kim JA, Kim HL. 2001. Cell-free expression and functional reconstitution of CALM in clathrin assembly. Exp Mol Med 33:89-94.
26. Kim JA, Kim SR, Jung YK, Woo SY, Seoh JY, Hong YS, Kim HL. 2000. Properties of GST-CALM expressed in E. coli. Exp Mol Med 32:93-99.
27. Kobayashi H, Hosoda F, Maseki N, Sakurai M, Imashuku S, Ohki M, Kaneko Y. 1997. Hematologic malignancies with the t(10; 11)(p13;q21) have the same molecular event and a variety of morphologic or immunologic phenotypes. Genes Chromosomes Cancer 20:253-259.
28. Kumon K, Kobayashi H, Maseki N, Sakashita A, Sakurai M, Tanizawa A, Imashuku S, Kaneko Y. 1999. Mixed-lineage leukemia with t(10;11)(p13;q21): an analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features. Genes Chromosomes Cancer 25:33-39.
29. Lavau C, Szilvassy SJ, Slany R, Cleary ML. 1997. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J 16:4226-4237.
30. Lillington DM, Young BD, Berger R, Martineau M, Moorman AV, Secker-Walker LM. 1998. The t(10;11)(p12;q23) translocation in acute leukaemia: a cytogenetic and clinical study of 20 patients. European 11q23 Workshop participants. Leukemia 12:801-804.
31. Lim DS, Kirsch DG, Canman CE, Ahn JH, Ziv Y, Newman LS, Darnell RB, Shiloh Y, Kastan MB. 1998. ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci USA 95:10146-10151.
32. Makowski GS, Davis EL, Aslanzadeh J, Hopfer SM. 1995. Enhanced direct amplification of Guthrie card DNA following selective elution of PCR inhibitors. Nucleic Acids Res 23:3788-3789.
33. Megonigal MD, Cheung NK, Rappaport EF, Nowell PC, Wilson RB, Jones DH, Addya K, Leonard DG, Kushner BH, Williams TM, Lange BJ, Felix CA. 2000a. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Proc Natl Acad Sci USA 97:2814-2819.
34. Megonigal MD, Rappaport EF, Wilson RB, Jones DH, Whitlock JA, Ortega JA, Slater DJ, Nowell PC, Felix CA. 2000b. Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes. Proc Natl Acad Sci USA 97:9597-9602.
35. Narita M, Shimizu K, Hayashi Y, Taki T, Taniwaki M, Hosoda F, Kobayashi H, Nakamura H, Sadamori N, Ohnishi H, Bessho F, Yanagisawa M, Ohki M. 1999. Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcripts. Br J Haematol 105:928-937.
36. Peyrard M, Fransson I, Xie YG, Han FY, Ruttledge MH, Swahn S, Collins JE, Dunham I, Collins VP, Dumanski JP. 1994. Characterization of a new member of the human beta-adaptin gene family from chromosome 22q12, a candidate meningioma gene. Hum Mol Genet 3:1393-1399.
37. Ross JA. 1998. Maternal diet and infant leukemia: a role for DNA topoisomerase II inhibitors? Int J Cancer Suppl 11:26-28.
38. Ross JA. 2000. Dietary flavonoids and the MLL gene: a pathway to infant leukemia? Proc Natl Acad Sci USA 97:4411-4413.
39. Rowley JD. 1998. Backtracking leukemia to birth. Nat Med 4:150-151.
40. Salmon-Nguyen F, Busson M, Daniel M, Leblanc T, Bernard OA, Berger R. 2000. CALM-AF10 fusion gene in leukemias: simple and inversion-associated translocation (10;11). Cancer Genet Cytogenet 122:137-140.
41. Santolini E, Salcini AE, Kay BK, Yamabhai M, Di Fiore PP. 1999. The EH network. Exp Cell Res 253:186-209.
42. Shapiro MB, Senapathy P. 1987. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155-7174.
43. Silliman CC, McGavran L, Wei Q, Miller LA, Li S, Hunger SP. 1998. Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a potential role for truncated AF10 polypeptides. Leukemia 12:1404-1410.
44. Slany RK, Lavau C, Cleary ML. 1998a. HRX DNA binding motifs and ENL transcriptional transactivation are essential requirements for the oncogenic capacity of the HRX-ENL fusion oncoprotein. Mol Cell Biol 16:4226-4237.
45. Slany RK, Lavau C, Cleary ML. 1998b. The oncogenic capacity of HRX-ENL requires the transcriptional, transactivation activity of ENL and the DNA binding motifs of HRX. Mol Cell Biol 18:122-129.
46. So CW, Caldas C, Liu MM, Chen SJ, Huang QH, Gu LJ, Sham MH, Wiedemann LM, Chan LC. 1997. EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. Proc Natl Acad Sci USA 94:2563-2568.
47. So CW, So CK, Cheung N, Chew SL, Sham MH, Chan LC. 2000. The interaction between EEN and Abi-1, two MLL fusion partners, and synaptojanin and dynamin: implications for leukaemogenesis. Leukemia 14:594-601.
48. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. 2000. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA 97:4790-4795.
49. Taki T, Shibuya N, Taniwaki M, Hanada R, Morishita K, Bessho F, Yanagisawa M, Hayashi Y. 1998. ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23). Blood 92:1125-1130.
50. Tebar F, Bohlander SK, Sorkin A. 1999. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol Biol Cell 10:2687-2702.
51. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, Le Beau MM, Diaz MO, Rowley JD. 1993. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 329:909-914.
52. Vecchi M, Polo S, Poupon V, van de Loo JW, Benmerah A, Di Fiore PP. 2001. Nucleocytoplasmic shuttling of endocytic proteins. J Cell Biol 153:1511-1517.
53. Vieira AV, Lamaze C, Schmid SL. 1996. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274:2086-2089.